Matthew Bakos, MD
Dermatology · Dayton, OHNPI 1861587115
Payments from drug & device makers
Across 689 payments — averaging $244.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$161K
- Regeneron Healthcare Solutions, Inc.$1K
- Johnson & Johnson$1K
- Lilly USA, LLC$573
- Sanofi$459
- Pfizer$406
- plus $3K from 27 others
What the payments were for
- Speaking & faculty fees$153,94191%
- Travel & lodging$3,1422%
- Food & beverage$10,9606%
- Education$6400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 292 | $161,312 |
| Regeneron Healthcare Solutions, Inc. | 58 | $1,350 |
| Johnson & Johnson | 50 | $1,138 |
| Lilly USA, LLC | 39 | $573 |
| Sanofi | 28 | $459 |
| Pfizer | 29 | $406 |
| UCB, Inc. | 19 | $405 |
| E.r. Squibb & Sons, L.L.C. | 26 | $401 |
| Novartis | 20 | $386 |
| Amgen | 11 | $248 |
| Arcutis Biotherapeutics, Inc. | 21 | $241 |
| Dermavant Sciences, Inc. | 22 | $227 |
| Sun Pharmaceutical Industries Inc. | 8 | $151 |
| Revance Therapeutics, Inc. | 1 | $148 |
| Galderma Laboratories, L.p. | 9 | $141 |
| VYNE Pharmaceuticals Inc. | 7 | $127 |
| Sanofi-aventis U.S. LLC | 3 | $126 |
| Prugen, Inc. Pharmaceuticals | 3 | $114 |
| Boehringer Ingelheim | 6 | $114 |
| Incyte Corporation | 4 | $89 |
| EPI Health, LLC | 4 | $82 |
| Mayne Pharma Commercial LLC | 4 | $61 |
| Journey Medical Corporation | 5 | $60 |
| Almirall LLC | 3 | $60 |
| Genentech USA, Inc. | 3 | $51 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $47 |
| Biofrontera Inc. | 3 | $38 |
| Dermira, Inc. | 2 | $37 |
| LEO Pharma Inc. | 2 | $31 |
| Krystal Biotech Inc | 1 | $19 |
| Organon | 1 | $16 |
| Strata Skin Sciences, Inc. | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$109,267
- BOTOX COSMETIC$9,000
- KYBELLA$1,950
- DAXXIFY$148
How this compares
$168,682 in reported general payments places this provider in the 90th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 49 | $381,449 |
| Dupixent PenDupilumab | 43 | $165,244 |
| Dupixent SyringeDupilumab | 25 | $95,720 |
| Clobetasol Propionate | 377 | $21,474 |
| Acitretin | 19 | $11,674 |
| Fluorouracil | 72 | $7,922 |
| Doxycycline Hyclate | 284 | $6,595 |
| Metronidazole | 73 | $3,673 |
| Ketoconazole | 238 | $3,062 |
| Triamcinolone Acetonide | 284 | $2,100 |
| Dutasteride | 60 | $1,661 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 22 | $1,581 |
| Minocycline Hcl | 83 | $1,374 |
| ValacyclovirValacyclovir Hcl | 82 | $1,374 |
| Clindamycin Phosphate | 20 | $1,149 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Dayton
- Jeffrey TraversDayton$4.7M
- Rocco SerraoDayton$3M
- Matthew ZirwasBexley$7.4M
- Neil KormanCleveland$6M
- Jennifer NashWesterville$4M
- Jessica KaffenbergerColumbus$3.2M
- Patrick ShannonBoardman$2M
- George DrewMarion$2M
- Benjamin BoguckiColumbus$2M
- Michelle ChambersColumbus$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.